UB Health Sciences Excel in NIH Funding Rankings
BUFFALO, N.Y., February 25, 2026 University at Buffalo (UB) health sciences programs delivered impressive showings in the latest Blue...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BUFFALO, N.Y., February 25, 2026 University at Buffalo (UB) health sciences programs delivered impressive showings in the latest Blue...
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
PROVIDENCE, R.I., Feb. 11, 2026 — Portal Innovations announced the expansion of its Powered by Portal venture development platform...
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ — Alamar Biosciences, a leader in precision proteomics, today announced the launch of...
